IDEAYA Biosciences inks deal with Hengrui Pharma for SHR-4849 ADC therapy
January 2025- IDEAYA Biosciences, Inc. announced that it has entered into an…
What is HMPV? A new virus or global threat? quick answers
Reports appearing from China point to a noticeable rise in respiratory infections,…
Merck enters into exclusive global license agreement with Hansoh Pharma
December 2024- Merck, known as MSD outside of the United States and…
Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca's Imfinzi (durvalumab) combined with chemotherapy to treat…
Climate Change Impact on Children’s Health: A Growing Crisis
Climate-related environmental disasters have continued to wreak havoc this summer, with heatwaves…
Clearing the Air: The Global Battle Against Air Pollution and Its Impact on Health
Air pollution is a silent menace that affects us all, but its…